Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Drug Resistance

  Free Subscription

Articles published in Emerg Infect Dis

Retrieve available abstracts of 104 articles:
HTML format

Single Articles

    April 2020
  1. SALOMAO MC, Freire MP, Boszczowski I, Raymundo SF, et al
    Increased Risk for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available

    March 2020
  2. CAMPBELL JR, Falzon D, Mirzayev F, Jaramillo E, et al
    Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available

  3. PARIKH MP, Octaria R, Kainer MA
    Methicillin-Resistant Staphylococcus aureus Bloodstream Infections and Injection Drug Use, Tennessee, USA, 2015-2017.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available

  4. CHEN Y, Marimuthu K, Teo J, Venkatachalam I, et al
    Acquisition of Plasmid with Carbapenem-Resistance Gene blaKPC2 in Hypervirulent Klebsiella pneumoniae, Singapore.
    Emerg Infect Dis. 2020;26:549-559.
    PubMed     Abstract available

    February 2020
  5. VESTY A, McAuliffe G, Roberts S, Henderson G, et al
    Mycoplasma genitalium Antimicrobial Resistance in Community and Sexual Health Clinic Patients, Auckland, New Zealand.
    Emerg Infect Dis. 2020;26:332-335.
    PubMed     Abstract available

  6. ZHOU K, Xiao T, David S, Wang Q, et al
    Novel Subclone of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 with Enhanced Virulence and Transmissibility, China.
    Emerg Infect Dis. 2020;26:289-297.
    PubMed     Abstract available

  7. SKINNER AM, Petrella L, Siddiqui F, Sambol SP, et al
    Unique Clindamycin-Resistant Clostridioides difficile Strain Related to Fluoroquinolone-Resistant Epidemic BI/RT027 Strain.
    Emerg Infect Dis. 2020;26:247-254.
    PubMed     Abstract available

    January 2020
  8. CHAE C, Davies NG, Jit M, Atkins KE, et al
    Effect of Pediatric Influenza Vaccination on Antibiotic Resistance, England and Wales.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available

    December 2019
  9. FRENCH NP, Zhang J, Carter GP, Midwinter AC, et al
    Genomic Analysis of Fluoroquinolone- and Tetracycline-Resistant Campylobacter jejuni Sequence Type 6964 in Humans and Poultry, New Zealand, 2014-2016.
    Emerg Infect Dis. 2019;25:2226-2234.
    PubMed     Abstract available

  10. LI L, Deng J, Ma X, Zhou K, et al
    High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016.
    Emerg Infect Dis. 2019;25:2205-2214.
    PubMed     Abstract available

    November 2019
  11. ADELANTADO M, Navascues A, Beristain X, Gil-Setas A, et al
    Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014-2017.
    Emerg Infect Dis. 2019;25.

  12. BAFFOE-BONNIE A, Houpt ER, Turner L, Dodge D, et al
    Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis in a Single Patient.
    Emerg Infect Dis. 2019;25.
    PubMed     Abstract available

    October 2019
  13. HU YY, Cao JM, Yang Q, Chen S, et al
    Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa, Zhejiang Province, China.
    Emerg Infect Dis. 2019;25:1861-1867.
    PubMed     Abstract available

    September 2019
  14. VAN SCHALKWYK E, Mpembe RS, Thomas J, Shuping L, et al
    Epidemiologic Shift in Candidemia Driven by Candida auris, South Africa, 2016-2017(1).
    Emerg Infect Dis. 2019;25:1698-1707.
    PubMed     Abstract available

  15. CHEN PY, Chuang YC, Wu UI, Sun HY, et al
    Clonality of Fluconazole-Nonsusceptible Candida tropicalis in Bloodstream Infections, Taiwan, 2011-2017.
    Emerg Infect Dis. 2019;25:1660-1667.
    PubMed     Abstract available

  16. AIRES-DE-SOUSA M, Ortiz de la Rosa JM, Goncalves ML, Pereira AL, et al
    Epidemiology of Carbapenemase-Producing Klebsiella pneumoniae in a Hospital, Portugal.
    Emerg Infect Dis. 2019;25:1632-1638.
    PubMed     Abstract available

  17. BERENGER BM, Demczuk W, Gratrix J, Pabbaraju K, et al
    Genetic Characterization and Enhanced Surveillance of Ceftriaxone-Resistant Neisseria gonorrhoeae Strain, Alberta, Canada, 2018.
    Emerg Infect Dis. 2019;25:1660-1667.
    PubMed     Abstract available

    August 2019
  18. ROJAS R, Macesic N, Tolari G, Guzman A, et al
    Multidrug-Resistant Klebsiella pneumoniae ST307 in Traveler Returning from Puerto Rico to Dominican Republic.
    Emerg Infect Dis. 2019;25:1583-1585.
    PubMed     Abstract available

    July 2019
  19. WALTERS MS, Grass JE, Bulens SN, Hancock EB, et al
    Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015.
    Emerg Infect Dis. 2019;25:1281-1288.
    PubMed     Abstract available

  20. RIZZO K, Horwich-Scholefield S, Epson E
    Carbapenem and Cephalosporin Resistance among Enterobacteriaceae in Healthcare-Associated Infections, California, USA(1).
    Emerg Infect Dis. 2019;25:1389-1393.
    PubMed     Abstract available

  21. LANGELIER C, Graves M, Kalantar K, Caldera S, et al
    Microbiome and Antimicrobial Resistance Gene Dynamics in International Travelers.
    Emerg Infect Dis. 2019;25:1380-1383.
    PubMed     Abstract available

  22. MARTENS L, Kuster S, de Vos W, Kersten M, et al
    Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014-2017.
    Emerg Infect Dis. 2019;25:1297-1303.
    PubMed     Abstract available

  23. SCHOUSTRA SE, Debets AJM, Rijs AJMM, Zhang J, et al
    Environmental Hotspots for Azole Resistance Selection of Aspergillus fumigatus, the Netherlands.
    Emerg Infect Dis. 2019;25:1347-1353.
    PubMed     Abstract available

  24. ARMSTRONG PA, Rivera SM, Escandon P, Caceres DH, et al
    Hospital-Associated Multicenter Outbreak of Emerging Fungus Candida auris, Colombia, 2016.
    Emerg Infect Dis. 2019;25.
    PubMed     Abstract available

  25. LOPES BS, Strachan NJC, Ramjee M, Thomson A, et al
    Nationwide Stepwise Emergence and Evolution of Multidrug-Resistant Campylobacter jejuni Sequence Type 5136, United Kingdom.
    Emerg Infect Dis. 2019;25:1320-1329.
    PubMed     Abstract available

  26. HUANG F, van den Hof S, Qu Y, Li Y, et al
    Added Value of Comprehensive Program to Provide Universal Access to Care for Sputum Smear-Negative Drug-Resistant Tuberculosis, China.
    Emerg Infect Dis. 2019;25:1289-1296.
    PubMed     Abstract available

  27. CHEN SC, Han Y, Yuan LF, Zhu XY, et al
    Identification of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain FC428, China.
    Emerg Infect Dis. 2019;25:1427-1429.
    PubMed     Abstract available

    May 2019
  28. MBUAGBAW L, Guglielmetti L, Hewison C, Bakare N, et al
    Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis.
    Emerg Infect Dis. 2019;25:936-943.
    PubMed     Abstract available

    April 2019
  29. LOWE M, Kock MM, Coetzee J, Hoosien E, et al
    Klebsiella pneumoniae ST307 with blaOXA-181, South Africa, 2014-2016.
    Emerg Infect Dis. 2019;25:739-747.
    PubMed     Abstract available

  30. ABED Y, Fage C, Lague P, Carbonneau J, et al
    Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada.
    Emerg Infect Dis. 2019;25:838-840.
    PubMed     Abstract available

  31. LA COMBE B, Clermont O, Messika J, Eveillard M, et al
    Pneumonia-Specific Escherichia coli with Distinct Phylogenetic and Virulence Profiles, France, 2012-2014.
    Emerg Infect Dis. 2019;25:710-718.
    PubMed     Abstract available

  32. READ TRH, Murray GL, Danielewski JA, Fairley CK, et al
    Symptoms, Sites, and Significance of Mycoplasma genitalium in Men Who Have Sex with Men.
    Emerg Infect Dis. 2019;25:719-727.
    PubMed     Abstract available

    March 2019
  33. HOLLAND DP, Alexander S, Onwubiko U, Goswami ND, et al
    Response to Isoniazid-Resistant Tuberculosis in Homeless Shelters, Georgia, USA, 2015-2017.
    Emerg Infect Dis. 2019;25:593-595.
    PubMed     Abstract available

  34. LOVEDAY M, Hlangu S, Furin J
    Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis.
    Emerg Infect Dis. 2019;25:609-610.
    PubMed     Abstract available

  35. LEE H, Suh YH, Lee S, Kim YK, et al
    Emergence and Spread of Cephalosporin-Resistant Neisseria gonorrhoeae with Mosaic penA Alleles, South Korea, 2012-2017.
    Emerg Infect Dis. 2019;25:416-424.
    PubMed     Abstract available

  36. PARK JY, Bradley N, Brooks S, Burney S, et al
    Management of Patients with Candida auris Fungemia at Community Hospital, Brooklyn, New York, USA, 2016-2018(1).
    Emerg Infect Dis. 2019;25:601-602.
    PubMed     Abstract available

  37. SKIBA Y, Mokrousov I, Nabirova D, Vyazovaya A, et al
    Mycobacterium tuberculosis RD-Rio Strain in Kazakhstan.
    Emerg Infect Dis. 2019;25:604-606.
    PubMed     Abstract available

  38. BROWNE AS, Biggs PJ, Wilkinson DA, Cookson AL, et al
    Use of Genomics to Investigate Historical Importation of Shiga Toxin-Producing Escherichia coli Serogroup O26 and Nontoxigenic Variants into New Zealand.
    Emerg Infect Dis. 2019;25:489-500.
    PubMed     Abstract available

  39. LEPUSCHITZ S, Ruppitsch W, Pekard-Amenitsch S, Forsythe SJ, et al
    Multicenter Study of Cronobacter sakazakii Infections in Humans, Europe, 2017.
    Emerg Infect Dis. 2019;25:515-522.
    PubMed     Abstract available

  40. BOUZOUITA I, Cabibbe AM, Trovato A, Daroui H, et al
    Whole-Genome Sequencing of Drug-Resistant Mycobacterium tuberculosis Strains, Tunisia, 2012-2016.
    Emerg Infect Dis. 2019;25:538-546.
    PubMed     Abstract available

  41. HARE RK, Gertsen JB, Astvad KMT, Degn KB, et al
    In Vivo Selection of a Unique Tandem Repeat Mediated Azole Resistance Mechanism (TR120) in Aspergillus fumigatus cyp51A, Denmark.
    Emerg Infect Dis. 2019;25:577-580.
    PubMed     Abstract available

  42. LIPWORTH S, Jajou R, de Neeling A, Bradley P, et al
    SNP-IT Tool for Identifying Subspecies and Associated Lineages of Mycobacterium tuberculosis Complex.
    Emerg Infect Dis. 2019;25:482-488.
    PubMed     Abstract available

  43. EL ACHKAR S, Demanche C, Osman M, Rafei R, et al
    Drug-Resistant Tuberculosis, Lebanon, 2016 - 2017.
    Emerg Infect Dis. 2019;25:564-568.
    PubMed     Abstract available

    January 2019
  44. KOECK M, Como-Sabetti K, Boxrud D, Dobbins G, et al
    Burdens of Invasive Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Disease, Minnesota, USA.
    Emerg Infect Dis. 2019;25:171-174.
    PubMed     Abstract available

  45. SUN L, Chen Y, Wang D, Wang H, et al
    Surgical Site Infections Caused by Highly Virulent Methicillin-Resistant Staphylococcus aureus Sequence Type 398, China.
    Emerg Infect Dis. 2019;25:157-160.
    PubMed     Abstract available

  46. NADIMPALLI M, Vuthy Y, de Lauzanne A, Fabre L, et al
    Meat and Fish as Sources of Extended-Spectrum beta-Lactamase-Producing Escherichia coli, Cambodia.
    Emerg Infect Dis. 2019;25.
    PubMed     Abstract available

  47. CHIOU CS, Hong YP, Liao YS, Wang YW, et al
    New Multidrug-Resistant Salmonella enterica Serovar Anatum Clone, Taiwan, 2015-2017.
    Emerg Infect Dis. 2019;25:144-147.
    PubMed     Abstract available

  48. EWING AC, Davis NL, Kayira D, Hosseinipour MC, et al
    Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004-2010.
    Emerg Infect Dis. 2019;25.
    PubMed     Abstract available

  49. CONLON-BINGHAM GM, Aldeyab M, Scott M, Kearney MP, et al
    Effects of Antibiotic Cycling Policy on Incidence of Healthcare-Associated MRSA and Clostridioides difficile Infection in Secondary Healthcare Settings.
    Emerg Infect Dis. 2019;25:52-62.
    PubMed     Abstract available

  50. BUIL JB, Snelders E, Denardi LB, Melchers WJG, et al
    Trends in Azole Resistance in Aspergillus fumigatus, the Netherlands, 1994-2016.
    Emerg Infect Dis. 2019;25:176-178.
    PubMed     Abstract available

    November 2018
  51. UBUKATA K, Takata M, Morozumi M, Chiba N, et al
    Effects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010-2017.
    Emerg Infect Dis. 2018;24:2010-2020.
    PubMed     Abstract available

    August 2018
  52. LEE JK, Lee JH, Lee H, Ahn YM, et al
    Clonal Expansion of Macrolide-Resistant Sequence Type 3 Mycoplasma pneumoniae, South Korea.
    Emerg Infect Dis. 2018;24:1465-1471.
    PubMed     Abstract available

  53. ALSAN M, Kammili N, Lakshmi J, Xing A, et al
    Poverty and Community-Acquired Antimicrobial Resistance with Extended-Spectrum beta-Lactamase-Producing Organisms, Hyderabad, India.
    Emerg Infect Dis. 2018;24:1490-1496.
    PubMed     Abstract available

  54. BEYROUTHY R, Barets M, Marion E, Dananche C, et al
    Novel Enterobacter Lineage as Leading Cause of Nosocomial Outbreak Involving Carbapenemase-Producing Strains.
    Emerg Infect Dis. 2018;24:1505-1515.
    PubMed     Abstract available

  55. WILLIAMS DL, Araujo S, Stryjewska BM, Scollard D, et al
    Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
    Emerg Infect Dis. 2018;24:1584-1585.
    PubMed     Abstract available

  56. PEKARD-AMENITSCH S, Schriebl A, Posawetz W, Willinger B, et al
    Isolation of Candida auris from Ear of Otherwise Healthy Patient, Austria, 2018.
    Emerg Infect Dis. 2018;24:1596-1597.
    PubMed     Abstract available

  57. WHILEY DM, Mhango L, Jennison AV, Nimmo G, et al
    Direct Detection of penA Gene Associated with Ceftriaxone-Resistant Neisseria gonorrhoeae FC428 Strain by Using PCR.
    Emerg Infect Dis. 2018;24:1573-1575.
    PubMed     Abstract available

    July 2018
  58. KENYON CR, Schwartz IS
    Effects of Sexual Network Connectivity and Antimicrobial Drug Use on Antimicrobial Resistance in Neisseria gonorrhoeae.
    Emerg Infect Dis. 2018;24:1195-1203.
    PubMed     Abstract available

    June 2018
  59. PEIRANO G, Matsumura Y, Adams MD, Bradford P, et al
    Genomic Epidemiology of Global Carbapenemase-Producing Enterobacter spp., 2008-2014.
    Emerg Infect Dis. 2018;24:1010-1019.
    PubMed     Abstract available

  60. FERNANDES MR, Sellera FP, Moura Q, Carvalho MPN, et al
    Zooanthroponotic Transmission of Drug-Resistant Pseudomonas aeruginosa, Brazil.
    Emerg Infect Dis. 2018;24:1160-1162.
    PubMed     Abstract available

    May 2018
  61. FOX-LEWIS A, Takata J, Miliya T, Lubell Y, et al
    Antimicrobial Resistance in Invasive Bacterial Infections in Hospitalized Children, Cambodia, 2007-2016.
    Emerg Infect Dis. 2018;24:841-851.
    PubMed     Abstract available

  62. JANSSEN H, Janssen I, Cooper P, Kainyah C, et al
    Antimicrobial-Resistant Bacteria in Infected Wounds, Ghana, 2014(1).
    Emerg Infect Dis. 2018;24:916-919.
    PubMed     Abstract available

    April 2018
  63. CHEN SC, Yin YP, Chen XS
    Cephalosporin-Resistant Neisseria gonorrhoeae Clone, China.
    Emerg Infect Dis. 2018;24:804-806.
    PubMed     Abstract available

  64. ISIDRO J, Santos A, Nunes A, Borges V, et al
    Imipenem Resistance in Clostridium difficile Ribotype 017, Portugal.
    Emerg Infect Dis. 2018;24:741-745.
    PubMed     Abstract available

  65. BULENS SN, Yi SH, Walters MS, Jacob JT, et al
    Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015.
    Emerg Infect Dis. 2018;24:727-734.
    PubMed     Abstract available

  66. LAHRA MM, Martin I, Demczuk W, Jennison AV, et al
    Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain.
    Emerg Infect Dis. 2018;24.
    PubMed     Abstract available

  67. MENDES AC, Novais A, Campos J, Rodrigues C, et al
    mcr-1 in Carbapenemase-Producing Klebsiella pneumoniae with Hospitalized Patients, Portugal, 2016-2017.
    Emerg Infect Dis. 2018;24:762-766.
    PubMed     Abstract available

  68. ARNOTT A, Wang Q, Bachmann N, Sadsad R, et al
    Multidrug-Resistant Salmonella enterica 4,[5],12:i:- Sequence Type 34, New South Wales, Australia, 2016-2017.
    Emerg Infect Dis. 2018;24:751-753.
    PubMed     Abstract available

  69. HUYNH BT, Kermorvant-Duchemin E, Herindrainy P, Padget M, et al
    Bacterial Infections in Neonates, Madagascar, 2012-2014.
    Emerg Infect Dis. 2018;24:710-717.
    PubMed     Abstract available

    March 2018
  70. CHERNYAEVA E, Rotkevich M, Krasheninnikova K, Yurchenko A, et al
    Whole-Genome Analysis of Mycobacterium tuberculosis from Patients with Tuberculous Spondylitis, Russia.
    Emerg Infect Dis. 2018;24:579-583.
    PubMed     Abstract available

  71. RANDO-SEGURA A, Aznar ML, Moreno MM, Espasa M, et al
    Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.
    Emerg Infect Dis. 2018;24:569-572.
    PubMed     Abstract available

  72. NAIK PR, Moonan PK, Nirgude AS, Shewade HD, et al
    Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India.
    Emerg Infect Dis. 2018;24:478-484.
    PubMed     Abstract available

  73. LOUTET MG, Davidson JA, Brown T, Dedicoat M, et al
    Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000-2015.
    Emerg Infect Dis. 2018;24:524-533.
    PubMed     Abstract available

    February 2018
  74. BECKER K, van Alen S, Idelevich EA, Schleimer N, et al
    Plasmid-Encoded Transferable mecB-Mediated Methicillin Resistance in Staphylococcus aureus.
    Emerg Infect Dis. 2018;24:242-248.
    PubMed     Abstract available

  75. READ TRH, Jensen JS, Fairley CK, Grant M, et al
    Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection.
    Emerg Infect Dis. 2018;24:328-335.
    PubMed     Abstract available

  76. NAKANO S, Fujisawa T, Ito Y, Chang B, et al
    Spread of Meropenem-Resistant Streptococcus pneumoniae Serotype 15A-ST63 Clone in Japan, 2012-2014.
    Emerg Infect Dis. 2018;24:275-283.
    PubMed     Abstract available

  77. LEFEBVRE B, Martin I, Demczuk W, Deshaies L, et al
    Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017.
    Emerg Infect Dis. 2018;24.
    PubMed     Abstract available

    January 2018
  78. WALKER TA, Lockhart SR, Beekmann SE, Polgreen PM, et al
    Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States.
    Emerg Infect Dis. 2018;24.
    PubMed     Abstract available

  79. KAJUMBULA H, Fujita AW, Mbabazi O, Najjuka C, et al
    Antimicrobial Drug Resistance in Blood Culture Isolates at a Tertiary Hospital, Uganda.
    Emerg Infect Dis. 2018;24:174-175.
    PubMed     Abstract available

  80. LEVIS W, Rendini T, Martiniuk F
    Increasing Virulence in Leprosy Indicated by Global Mycobacterium spp.
    Emerg Infect Dis. 2018;24:183a-184.

    November 2017
  81. GUO Y, Tomich AD, McElheny CL, Cooper VS, et al
    High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium.
    Emerg Infect Dis. 2017;23:1902-1904.
    PubMed     Abstract available

    October 2017
  82. TANAKA T, Oishi T, Miyata I, Wakabayashi S, et al
    Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
    Emerg Infect Dis. 2017;23:1703-1706.
    PubMed     Abstract available

  83. FILIPE M, Reimer A, Matuschek E, Paul M, et al
    Fluoroquinolone-Resistant Alcaligenes faecalis Related to Chronic Suppurative Otitis Media, Angola.
    Emerg Infect Dis. 2017;23:1740-1742.
    PubMed     Abstract available

    September 2017
  84. WHILEY DM, Trembizki E, Buckley C, Freeman K, et al
    Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.
    Emerg Infect Dis. 2017;23:1478-1485.
    PubMed     Abstract available

    August 2017
  85. MOWLABOCCUS S, Jolley KA, Bray JE, Pang S, et al
    Clonal Expansion of New Penicillin-Resistant Clade of Neisseria meningitidis Serogroup W Clonal Complex 11, Australia.
    Emerg Infect Dis. 2017;23.
    PubMed     Abstract available

    June 2017
  86. ANDAM CP, Worby CJ, Gierke R, McGee L, et al
    Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States.
    Emerg Infect Dis. 2017;23:1012-1015.
    PubMed     Abstract available

    May 2017
  87. MURRAY GL, Bradshaw CS, Bissessor M, Danielewski J, et al
    Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium.
    Emerg Infect Dis. 2017;23:809-812.
    PubMed     Abstract available

  88. WILSON BM, El Chakhtoura NG, Patel S, Saade E, et al
    Carbapenem-Resistant Enterobacter cloacae in Patients from the US Veterans Health Administration, 2006-2015.
    Emerg Infect Dis. 2017;23:878-880.
    PubMed     Abstract available

  89. CASPAR Y, Maillet M, Pavese P, Francony G, et al
    mcr-1 Colistin Resistance in ESBL-Producing Klebsiella pneumoniae, France.
    Emerg Infect Dis. 2017;23:874-876.
    PubMed     Abstract available

  90. PAPP JR, Abrams AJ, Nash E, Katz AR, et al
    Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USA.
    Emerg Infect Dis. 2017;23:830-832.
    PubMed     Abstract available

  91. MYAT TO, Hannaway RF, Zin KN, Htike WW, et al
    ESBL- and Carbapenemase-Producing Enterobacteriaceae in Patients with Bacteremia, Yangon, Myanmar, 2014.
    Emerg Infect Dis. 2017;23:857-859.
    PubMed     Abstract available

  92. ABBARA A, Al-Harbat N, Karah N, Abo-Yahya B, et al
    Antimicrobial Drug Resistance among Refugees from Syria, Jordan.
    Emerg Infect Dis. 2017;23:885-886.

    April 2017
  93. LEI L, Wang Y, Schwarz S, Walsh TR, et al
    mcr-1 in Enterobacteriaceae from Companion Animals, Beijing, China, 2012-2016.
    Emerg Infect Dis. 2017;23:710-711.
    PubMed     Abstract available

  94. BARANOVICH T, Vongphrachanh P, Ketmayoon P, Sisouk T, et al
    Antiviral Drug-Resistant Influenza B Viruses Carrying H134N Substitution in Neuraminidase, Laos, February 2016.
    Emerg Infect Dis. 2017;23:686-690.
    PubMed     Abstract available

    March 2017
  95. BUTIN M, Martins-Simoes P, Rasigade JP, Picaud JC, et al
    Worldwide Endemicity of a Multidrug-Resistant Staphylococcus capitis Clone Involved in Neonatal Sepsis.
    Emerg Infect Dis. 2017;23:538-539.
    PubMed     Abstract available

  96. TRUNG NV, Matamoros S, Carrique-Mas JJ, Nghia NH, et al
    Zoonotic Transmission of mcr-1 Colistin Resistance Gene from Small-Scale Poultry Farms, Vietnam.
    Emerg Infect Dis. 2017;23:529-532.
    PubMed     Abstract available

    February 2017
  97. BEN-AMI R, Berman J, Novikov A, Bash E, et al
    Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel.
    Emerg Infect Dis. 2017;23.
    PubMed     Abstract available

  98. SHERRY L, Ramage G, Kean R, Borman A, et al
    Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.
    Emerg Infect Dis. 2017;23:328-331.
    PubMed     Abstract available

  99. ERIKSEN HB, Gumpert H, Faurholt CH, Westh H, et al
    Determination of Elizabethkingia Diversity by MALDI-TOF Mass Spectrometry and Whole-Genome Sequencing.
    Emerg Infect Dis. 2017;23:320-323.
    PubMed     Abstract available

  100. AMOUREUX L, Riedweg K, Chapuis A, Bador J, et al
    Nosocomial Infections with IMP-19-Producing Pseudomonas aeruginosa Linked to Contaminated Sinks, France.
    Emerg Infect Dis. 2017;23:304-307.
    PubMed     Abstract available

  101. YI L, Wang J, Gao Y, Liu Y, et al
    mcr-1-Harboring Salmonella enterica Serovar Typhimurium Sequence Type 34 in Pigs, China.
    Emerg Infect Dis. 2017;23:291-295.
    PubMed     Abstract available

    January 2017
  102. MORALES-LOPEZ SE, Parra-Giraldo CM, Ceballos-Garzon A, Martinez HP, et al
    Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia.
    Emerg Infect Dis. 2017;23:162-164.
    PubMed     Abstract available

  103. KASSEM DF, Hoffmann Y, Shahar N, Ocampo S, et al
    Multidrug-Resistant Pathogens in Hospitalized Syrian Children.
    Emerg Infect Dis. 2017;23:166-168.
    PubMed     Abstract available

    June 2016
  104. MOKROUSOV I, Chernyaeva E, Vyazovaya A, Sinkov V, et al
    Next-Generation Sequencing of Mycobacterium tuberculosis.
    Emerg Infect Dis. 2016;22:1127-9.

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.